Increased systemic oxidative stress in patients with keratoconus
Purpose To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus. Methods Twenty-five patients with keratoconus (keratoconus group) and 25 age–sex-matched heal...
Saved in:
Published in | Eye (London) Vol. 28; no. 3; pp. 285 - 289 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.03.2014
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 0950-222X 1476-5454 1476-5454 |
DOI | 10.1038/eye.2013.262 |
Cover
Loading…
Abstract | Purpose
To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus.
Methods
Twenty-five patients with keratoconus (keratoconus group) and 25 age–sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated.
Results
The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (
P
>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (
P
=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (
P
=0.497).
Conclusions
The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus. |
---|---|
AbstractList | Purpose
To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus.
Methods
Twenty-five patients with keratoconus (keratoconus group) and 25 age–sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated.
Results
The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (
P
>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (
P
=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (
P
=0.497).
Conclusions
The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus. To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus. Twenty-five patients with keratoconus (keratoconus group) and 25 age-sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated. The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (P>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (P=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (P=0.497). The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus. To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus. Twenty-five patients with keratoconus (keratoconus group) and 25 age-sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated. The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (P>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (P=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (P=0.497). The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus. To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus.PURPOSETo establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant status (TAS) in patients with keratoconus.Twenty-five patients with keratoconus (keratoconus group) and 25 age-sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated.METHODSTwenty-five patients with keratoconus (keratoconus group) and 25 age-sex-matched healthy subjects (control group) were enrolled in the study. Exclusion criteria were smoking habit, history of any other corneal pathology, systemic disease or inflammation, and current antioxidant or anti-inflammatory therapies. All participants underwent a detailed ophthalmological examination and corneal topography. Serum samples were obtained from all participants. Oxidative stress markers (TAS and TOS) were measured using a commercial kit and oxidative stress index (OSI) was calculated.The study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (P>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (P=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (P=0.497).RESULTSThe study comprised 25 patients with keratoconus (mean age of 26.4±1.7 years) and 25 healthy control subjects (mean age of 26.6±1.7 years) (P>0.05). The serum TOS and OSI values were significantly higher in patients with keratoconus compared with those of the controls (P=0.036 and 0.037, respectively). However, serum TAS did not show significant difference between the keratoconus and control groups (P=0.497).The higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus.CONCLUSIONSThe higher levels of serum oxidant status and OSI in patients with keratoconus suggest that systemic oxidative stress might be involved in the pathogenesis of keratoconus. |
Author | Kucukatay, V Kilic-Toprak, E Yildirim, C Toprak, I Kilic-Erkek, O |
Author_xml | – sequence: 1 givenname: I surname: Toprak fullname: Toprak, I email: ibrahimt@doctor.com organization: Department of Ophthalmology, Servergazi State Hospital – sequence: 2 givenname: V surname: Kucukatay fullname: Kucukatay, V organization: Department of Physiology, Faculty of Medicine, Pamukkale University – sequence: 3 givenname: C surname: Yildirim fullname: Yildirim, C organization: Department of Ophthalmology, Faculty of Medicine, Pamukkale University, Private Ege Akademi Eye Hospital – sequence: 4 givenname: E surname: Kilic-Toprak fullname: Kilic-Toprak, E organization: Department of Physiology, Faculty of Medicine, Pamukkale University – sequence: 5 givenname: O surname: Kilic-Erkek fullname: Kilic-Erkek, O organization: Department of Physiology, Faculty of Medicine, Pamukkale University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24310241$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1P3DAQxS0EKgvtjXMVqZceyNafcXJBVAgoElIvrdSb5dgTMM3ai-0A-9_j1QKiiJ5GmvnN05t5e2jbBw8IHRA8J5i132AFc4oJm9OGbqEZ4bKpBRd8G81wJ3BNKf2zi_ZSusG4DCX-gHYpZwRTTmbo-MKbCDqBrdIqZVg4U4UHZ3V2d1ClHCGlyvlqWRrgc6ruXb6u_kLUOZjgp_QR7Qx6TPDpqe6j32env05-1Jc_zy9Ovl_WRlCca6KFJpKxnnQD4daKXnRSENwXq2Jo254ZTixpNDGtFJRr03SgrTWtbTUfgO2jo43ucuoXYE0xE_WoltEtdFypoJ36d-LdtboKd4p1jWhxUwS-PgnEcDtBymrhkoFx1B7ClBQRWMpOMi4L-uUNehOm6Mt5a6ppMaZCFOrza0cvVp6fW4DDDWBiSCnC8IIQrNbZqZKdWmenSnYFp29w43J5e1jf48b_LdWbpVS0_RXEV1bf4x8BSraseQ |
CitedBy_id | crossref_primary_10_3928_01913913_20160831_01 crossref_primary_10_1167_iovs_18_24267 crossref_primary_10_61186_mlj_18_1_12 crossref_primary_10_1038_s41598_023_37472_8 crossref_primary_10_1016_j_jtos_2020_03_006 crossref_primary_10_1167_iovs_62_10_30 crossref_primary_10_3109_02713683_2015_1004717 crossref_primary_10_1080_09273948_2020_1741648 crossref_primary_10_1080_17469899_2024_2368801 crossref_primary_10_1167_iovs_66_2_60 crossref_primary_10_1097_OPX_0000000000001467 crossref_primary_10_3390_ijms23031255 crossref_primary_10_3390_nu14040913 crossref_primary_10_1111_ceo_14045 crossref_primary_10_1155_2017_9707650 crossref_primary_10_1016_j_jtos_2015_04_006 crossref_primary_10_1080_02713683_2017_1302592 crossref_primary_10_1111_aos_14714 crossref_primary_10_1194_jlr_M067264 crossref_primary_10_1097_ICO_0000000000000260 crossref_primary_10_3390_jcm13041168 crossref_primary_10_1111_ceo_13996 crossref_primary_10_1016_j_exer_2019_107897 crossref_primary_10_1080_02713683_2022_2025846 crossref_primary_10_1080_09273948_2019_1611876 crossref_primary_10_1016_j_joco_2019_06_003 crossref_primary_10_2147_OPTH_S301330 crossref_primary_10_1007_s10792_021_01949_0 crossref_primary_10_1007_s00438_016_1283_z crossref_primary_10_12677_HJO_2022_111013 crossref_primary_10_1080_17469899_2022_2085557 crossref_primary_10_1097_ICL_0000000000000620 crossref_primary_10_1016_j_exer_2020_108211 crossref_primary_10_1097_ICO_0000000000000510 crossref_primary_10_1177_0006355X241290980 crossref_primary_10_3390_metabo13020187 crossref_primary_10_3390_pharmaceutics15030865 crossref_primary_10_1097_ICO_0000000000000878 crossref_primary_10_1167_tvst_13_9_13 crossref_primary_10_1038_s41433_019_0388_0 crossref_primary_10_6061_clinics_2015_10_02 crossref_primary_10_1038_s41598_018_33490_z crossref_primary_10_1038_s41598_019_51502_4 crossref_primary_10_1097_ICO_0000000000003585 crossref_primary_10_1111_ceo_14215 crossref_primary_10_1080_09273948_2020_1817498 crossref_primary_10_1155_2020_9410952 crossref_primary_10_1167_iovs_63_5_12 crossref_primary_10_1186_s12886_022_02255_8 crossref_primary_10_3390_ijms24087437 crossref_primary_10_1038_eye_2015_63 crossref_primary_10_1155_2019_2453931 crossref_primary_10_1007_s10792_017_0672_6 crossref_primary_10_1177_11206721211000644 crossref_primary_10_1097_APO_0000000000000332 crossref_primary_10_1097_ICO_0000000000001018 crossref_primary_10_32604_mcb_2021_014071 crossref_primary_10_1038_s41598_017_13525_7 crossref_primary_10_1038_s41598_020_77122_x crossref_primary_10_1007_s10792_020_01434_0 crossref_primary_10_1016_j_nurpra_2017_05_016 crossref_primary_10_4103_ijo_IJO_3403_20 crossref_primary_10_3390_biomedicines11020292 crossref_primary_10_1038_s41433_021_01753_1 crossref_primary_10_1155_2016_1243819 |
Cites_doi | 10.1167/iovs.11-7732 10.1111/j.1755-3768.2011.02369.x 10.1016/j.clinbiochem.2003.10.014 10.1016/j.freeradbiomed.2008.07.021 10.1016/j.exer.2012.07.010 10.1016/j.clinbiochem.2005.08.008 10.1167/iovs.08-1969 10.1167/iovs.05-0828 10.1167/iovs.05-1500 10.1016/j.clinbiochem.2003.11.015 10.1097/00003226-199307000-00006 10.1167/iovs.04-0549 10.1097/ICL.0b013e31814fb64b 10.1016/0039-6257(84)90094-8 10.1167/iovs.04-1395 10.1186/1471-2334-6-114 10.1016/S0002-9394(03)00788-8 10.1016/S0039-6257(97)00119-7 10.1177/112067210001000305 10.1177/002215540205000306 |
ContentType | Journal Article |
Copyright | Royal College of Ophthalmologists 2014 Copyright Nature Publishing Group Mar 2014 Copyright © 2014 Royal College of Ophthalmologists 2014 Royal College of Ophthalmologists |
Copyright_xml | – notice: Royal College of Ophthalmologists 2014 – notice: Copyright Nature Publishing Group Mar 2014 – notice: Copyright © 2014 Royal College of Ophthalmologists 2014 Royal College of Ophthalmologists |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7X7 7XB 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1038/eye.2013.262 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Central Student MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Increased systemic oxidative stress in keratoconus |
EISSN | 1476-5454 |
EndPage | 289 |
ExternalDocumentID | PMC3965806 3244737451 24310241 10_1038_eye_2013_262 |
Genre | Journal Article |
GroupedDBID | --- -Q- .GJ 0R~ 29G 2WC 36B 39C 3O- 4.4 406 53G 5RE 6PF 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAWTL AAYZH ABAKF ABAWZ ABBRH ABCQX ABDBE ABFSG ABJNI ABLJU ABRTQ ABUWG ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACSTC ACZOJ ADBBV AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AEZWR AFBBN AFDZB AFFNX AFHIU AFKRA AFSHS AGAYW AGHAI AGQEE AHMBA AHSBF AHWEU AIGIU AILAN AIXLP AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS ATHPR AXYYD AYFIA BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP E3Z EBLON EBS EBX EE. EIOEI EJD EMB EMOBN F5P FDQFY FERAY FIGPU FIZPM FSGXE FYUFA GX1 HCIFZ HMCUK HYE HZ~ IWAJR JSO JZLTJ KQ8 L7B M1P M7P NQJWS O9- OK1 P2P PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT ROL RPM SNX SNYQT SOHCF SOJ SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 UKHRP W2D ZGI ZXP AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TK 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ K9. LK8 PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c520t-1a5a1733b19f14dd5b597510b5455f88b3c41d16a1c87524ac69eaddc8d8a4fe3 |
IEDL.DBID | BENPR |
ISSN | 0950-222X 1476-5454 |
IngestDate | Thu Aug 21 13:42:32 EDT 2025 Thu Sep 04 17:26:52 EDT 2025 Fri Jul 25 09:04:23 EDT 2025 Mon Jul 21 06:05:50 EDT 2025 Tue Jul 01 03:00:22 EDT 2025 Thu Apr 24 23:03:12 EDT 2025 Mon Jul 21 06:08:32 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | keratoconus antioxidant status oxidant status oxidative stress |
Language | English |
License | http://www.springer.com/tdm |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c520t-1a5a1733b19f14dd5b597510b5455f88b3c41d16a1c87524ac69eaddc8d8a4fe3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.nature.com/articles/eye2013262.pdf |
PMID | 24310241 |
PQID | 1506800255 |
PQPubID | 33647 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3965806 proquest_miscellaneous_1507797347 proquest_journals_1506800255 pubmed_primary_24310241 crossref_primary_10_1038_eye_2013_262 crossref_citationtrail_10_1038_eye_2013_262 springer_journals_10_1038_eye_2013_262 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-03-01 |
PublicationDateYYYYMMDD | 2014-03-01 |
PublicationDate_xml | – month: 03 year: 2014 text: 2014-03-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationSubtitle | The Scientific Journal of The Royal College of Ophthalmologists |
PublicationTitle | Eye (London) |
PublicationTitleAbbrev | Eye |
PublicationTitleAlternate | Eye (Lond) |
PublicationYear | 2014 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Horoz, Bolukbas, Bolukbas, Aslan, Koylu, Selek (CR20) 2006; 6 Kenney, Chwa, Atilano, Tran, Carballo, Saghizadeh (CR19) 2005; 46 Balasubramanian, Mohan, Pye, Willcox (CR24) 2012; 90 Arnal, Peris-Martínez, Menezo, Johnsen-Soriano, Romero (CR5) 2011; 52 Behndig, Karlsson, Johansson, Brannstrom, Marklund (CR8) 2001; 42 Smith, Easty (CR18) 2000; 10 Chwa, Atilano, Hertzog, Zheng, Langberg, Kim (CR16) 2008; 49 Saijyothi, Fowjana, Madhumathi, Rajeshwari, Thennarasu, Prema (CR23) 2012; 103 Buddi, Lin, Atilano, Zorapapel, Kenney, Brown (CR4) 2002; 50 Ferreira, Lerner, Brunzini, Evelson, Llesuy (CR11) 2004; 137 Rabinowitz (CR1) 1998; 42 Monnies (CR3) 2007; 33 Chwa, Atilano, Reddy, Jordan, Kim, Kenney (CR15) 2006; 47 Gondhowiardjo, van Haeringen (CR17) 1993; 12 Erel (CR10) 2004; 37 Harma, Harma, Erel (CR13) 2003; 133 Atilano, Coskun, Chwa, Jordan, Reddy, Le (CR14) 2005; 46 Shoham, Hadziahmetovic, Dunaief, Mydlarski, Schipper (CR7) 2008; 45 Zhou, Sawaguchi, Twining, Sugar, Feder, Yue (CR9) 1998; 39 Udar, Atilano, Brown, Holguin, Small, Nesburn (CR21) 2006; 47 Kenney, Brown, Rajeev (CR6) 2000; 26 Krachmer, Feder, Belin (CR2) 1984; 28 Erel (CR22) 2004; 37 Erel (CR12) 2005; 38 E Arnal (BFeye2013262_CR5) 2011; 52 MC Kenney (BFeye2013262_CR19) 2005; 46 YS Rabinowitz (BFeye2013262_CR1) 1998; 42 JH Krachmer (BFeye2013262_CR2) 1984; 28 TD Gondhowiardjo (BFeye2013262_CR17) 1993; 12 M Horoz (BFeye2013262_CR20) 2006; 6 O Erel (BFeye2013262_CR12) 2005; 38 SA Balasubramanian (BFeye2013262_CR24) 2012; 90 L Zhou (BFeye2013262_CR9) 1998; 39 O Erel (BFeye2013262_CR22) 2004; 37 A Shoham (BFeye2013262_CR7) 2008; 45 AV Saijyothi (BFeye2013262_CR23) 2012; 103 MC Kenney (BFeye2013262_CR6) 2000; 26 A Behndig (BFeye2013262_CR8) 2001; 42 O Erel (BFeye2013262_CR10) 2004; 37 CW Monnies (BFeye2013262_CR3) 2007; 33 M Chwa (BFeye2013262_CR16) 2008; 49 SR Atilano (BFeye2013262_CR14) 2005; 46 VA Smith (BFeye2013262_CR18) 2000; 10 N Udar (BFeye2013262_CR21) 2006; 47 R Buddi (BFeye2013262_CR4) 2002; 50 SM Ferreira (BFeye2013262_CR11) 2004; 137 M Chwa (BFeye2013262_CR15) 2006; 47 M Harma (BFeye2013262_CR13) 2003; 133 11850437 - J Histochem Cytochem. 2002 Mar;50(3):341-51 22960318 - Exp Eye Res. 2012 Oct;103:41-6 18718524 - Free Radic Biol Med. 2008 Oct 15;45(8):1047-55 15003729 - Clin Biochem. 2004 Apr;37(4):277-85 22413749 - Acta Ophthalmol. 2012 Jun;90(4):e303-9 15728537 - Invest Ophthalmol Vis Sci. 2005 Mar;46(3):823-32 16877401 - Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3345-51 14691728 - Swiss Med Wkly. 2003 Nov 1;133(41-42):563-6 8339559 - Cornea. 1993 Jul;12(4):310-4 18515575 - Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4361-9 14700645 - Am J Ophthalmol. 2004 Jan;137(1):62-9 16214125 - Clin Biochem. 2005 Dec;38(12):1103-11 16842626 - BMC Infect Dis. 2006;6:114 10656302 - CLAO J. 2000 Jan;26(1):10-3 6230745 - Surv Ophthalmol. 1984 Jan-Feb;28(4):293-322 14725941 - Clin Biochem. 2004 Feb;37(2):112-9 9620070 - Invest Ophthalmol Vis Sci. 1998 Jun;39(7):1117-24 16638997 - Invest Ophthalmol Vis Sci. 2006 May;47(5):1902-10 11071029 - Eur J Ophthalmol. 2000 Jul-Sep;10(3):215-26 11527942 - Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2293-6 17993819 - Eye Contact Lens. 2007 Nov;33(6 Pt 1):265-71 9493273 - Surv Ophthalmol. 1998 Jan-Feb;42(4):297-319 15790887 - Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1256-63 21969298 - Invest Ophthalmol Vis Sci. 2011;52(12):8592-7 |
References_xml | – volume: 52 start-page: 8592 year: 2011 end-page: 8597 ident: CR5 article-title: Oxidative stress in keratoconus? publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-7732 – volume: 90 start-page: e303 year: 2012 end-page: e309 ident: CR24 article-title: Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2011.02369.x – volume: 39 start-page: 1117 year: 1998 end-page: 1124 ident: CR9 article-title: Expression of degradative enzymes and protease inhibitors in corneas with keratoconus publication-title: Invest Ophthalmol Vis Sci – volume: 37 start-page: 112 year: 2004 end-page: 119 ident: CR10 article-title: A novel automated method to measure total antioxidant response against potent free radical reactions publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2003.10.014 – volume: 45 start-page: 1047 year: 2008 end-page: 1055 ident: CR7 article-title: Oxidative stress in diseases of the human cornea publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2008.07.021 – volume: 103 start-page: 41 year: 2012 end-page: 46 ident: CR23 article-title: Tear fluid small molecular antioxidants profiling shows lowered glutathione in keratoconus publication-title: Exp Eye Res doi: 10.1016/j.exer.2012.07.010 – volume: 38 start-page: 1103 year: 2005 end-page: 1111 ident: CR12 article-title: A new automated colorimetric method for measuring total oxidant status publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2005.08.008 – volume: 49 start-page: 4361 year: 2008 end-page: 4369 ident: CR16 article-title: Hypersensitive response to oxidative stress in keratoconus corneal fibroblasts publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.08-1969 – volume: 47 start-page: 1902 year: 2006 end-page: 1910 ident: CR15 article-title: Increased stress-induced generation of reactive oxygen species and apoptosis in human keratoconus fibroblasts publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.05-0828 – volume: 47 start-page: 3345 year: 2006 end-page: 3351 ident: CR21 article-title: SOD1: a candidate gene for keratoconus publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.05-1500 – volume: 42 start-page: 2293 year: 2001 end-page: 2296 ident: CR8 article-title: Superoxide dismutase isoenzymes in the normal and diseased human cornea publication-title: Invest Ophthalmol Vis Sci – volume: 37 start-page: 277 year: 2004 end-page: 285 ident: CR22 article-title: A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2003.11.015 – volume: 12 start-page: 310 year: 1993 end-page: 314 ident: CR17 article-title: Corneal aldehyde dehydrogenase, glutathione reductase, and glutathione s-transferase in pathologic corneas publication-title: Cornea doi: 10.1097/00003226-199307000-00006 – volume: 46 start-page: 823 year: 2005 end-page: 832 ident: CR19 article-title: Increased levels of catalase and cathepsin V/L2 but decreased TIMP-1 in keratoconus corneas: evidence that oxidative stress plays a role in this disorder publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.04-0549 – volume: 33 start-page: 265 year: 2007 end-page: 271 ident: CR3 article-title: Abnormal rubbing and keractectasia publication-title: Eye Contact Lens doi: 10.1097/ICL.0b013e31814fb64b – volume: 28 start-page: 293 year: 1984 end-page: 322 ident: CR2 article-title: Keratoconus and related noninflammatory corneal thinning disorders publication-title: Surv Ophthalmol doi: 10.1016/0039-6257(84)90094-8 – volume: 46 start-page: 1256 year: 2005 end-page: 1263 ident: CR14 article-title: Accumulation of mitochondrial DNA damage in keratoconus corneas publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.04-1395 – volume: 6 start-page: 114 year: 2006 ident: CR20 article-title: Oxidative stress in hepatitis C infected end-stage renal disease subjects publication-title: BMC Infect Dis doi: 10.1186/1471-2334-6-114 – volume: 133 start-page: 563 year: 2003 end-page: 566 ident: CR13 article-title: Increased oxidative stress in patients with hydatidiform mole publication-title: Swiss Med Wkly – volume: 137 start-page: 62 year: 2004 end-page: 69 ident: CR11 article-title: Oxidative stress markers in aqueous humor of glaucoma patients publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(03)00788-8 – volume: 42 start-page: 297 year: 1998 end-page: 319 ident: CR1 article-title: Keratoconus publication-title: Surv Ophthalmol doi: 10.1016/S0039-6257(97)00119-7 – volume: 26 start-page: 10 year: 2000 end-page: 13 ident: CR6 article-title: Everett Kinsey lecture. The elusive causes of keratoconus: a working hypothesis publication-title: CLAO J – volume: 10 start-page: 215 year: 2000 end-page: 226 ident: CR18 article-title: Matrix metalloproteinase 2: involvement in keratoconus publication-title: Eur J Ophthalmol doi: 10.1177/112067210001000305 – volume: 50 start-page: 341 year: 2002 end-page: 351 ident: CR4 article-title: Evidence of oxidative stress in human corneal diseases publication-title: J Histochem Cytochem doi: 10.1177/002215540205000306 – volume: 45 start-page: 1047 year: 2008 ident: BFeye2013262_CR7 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2008.07.021 – volume: 103 start-page: 41 year: 2012 ident: BFeye2013262_CR23 publication-title: Exp Eye Res doi: 10.1016/j.exer.2012.07.010 – volume: 52 start-page: 8592 year: 2011 ident: BFeye2013262_CR5 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.11-7732 – volume: 46 start-page: 1256 year: 2005 ident: BFeye2013262_CR14 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.04-1395 – volume: 10 start-page: 215 year: 2000 ident: BFeye2013262_CR18 publication-title: Eur J Ophthalmol doi: 10.1177/112067210001000305 – volume: 47 start-page: 1902 year: 2006 ident: BFeye2013262_CR15 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.05-0828 – volume: 46 start-page: 823 year: 2005 ident: BFeye2013262_CR19 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.04-0549 – volume: 33 start-page: 265 year: 2007 ident: BFeye2013262_CR3 publication-title: Eye Contact Lens doi: 10.1097/ICL.0b013e31814fb64b – volume: 26 start-page: 10 year: 2000 ident: BFeye2013262_CR6 publication-title: CLAO J – volume: 38 start-page: 1103 year: 2005 ident: BFeye2013262_CR12 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2005.08.008 – volume: 37 start-page: 277 year: 2004 ident: BFeye2013262_CR22 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2003.11.015 – volume: 42 start-page: 297 year: 1998 ident: BFeye2013262_CR1 publication-title: Surv Ophthalmol doi: 10.1016/S0039-6257(97)00119-7 – volume: 39 start-page: 1117 year: 1998 ident: BFeye2013262_CR9 publication-title: Invest Ophthalmol Vis Sci – volume: 47 start-page: 3345 year: 2006 ident: BFeye2013262_CR21 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.05-1500 – volume: 137 start-page: 62 year: 2004 ident: BFeye2013262_CR11 publication-title: Am J Ophthalmol doi: 10.1016/S0002-9394(03)00788-8 – volume: 42 start-page: 2293 year: 2001 ident: BFeye2013262_CR8 publication-title: Invest Ophthalmol Vis Sci – volume: 49 start-page: 4361 year: 2008 ident: BFeye2013262_CR16 publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.08-1969 – volume: 50 start-page: 341 year: 2002 ident: BFeye2013262_CR4 publication-title: J Histochem Cytochem doi: 10.1177/002215540205000306 – volume: 6 start-page: 114 year: 2006 ident: BFeye2013262_CR20 publication-title: BMC Infect Dis doi: 10.1186/1471-2334-6-114 – volume: 133 start-page: 563 year: 2003 ident: BFeye2013262_CR13 publication-title: Swiss Med Wkly – volume: 37 start-page: 112 year: 2004 ident: BFeye2013262_CR10 publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2003.10.014 – volume: 28 start-page: 293 year: 1984 ident: BFeye2013262_CR2 publication-title: Surv Ophthalmol doi: 10.1016/0039-6257(84)90094-8 – volume: 12 start-page: 310 year: 1993 ident: BFeye2013262_CR17 publication-title: Cornea doi: 10.1097/00003226-199307000-00006 – volume: 90 start-page: e303 year: 2012 ident: BFeye2013262_CR24 publication-title: Acta Ophthalmol doi: 10.1111/j.1755-3768.2011.02369.x – reference: 15728537 - Invest Ophthalmol Vis Sci. 2005 Mar;46(3):823-32 – reference: 11850437 - J Histochem Cytochem. 2002 Mar;50(3):341-51 – reference: 6230745 - Surv Ophthalmol. 1984 Jan-Feb;28(4):293-322 – reference: 16638997 - Invest Ophthalmol Vis Sci. 2006 May;47(5):1902-10 – reference: 16214125 - Clin Biochem. 2005 Dec;38(12):1103-11 – reference: 22960318 - Exp Eye Res. 2012 Oct;103:41-6 – reference: 15003729 - Clin Biochem. 2004 Apr;37(4):277-85 – reference: 14725941 - Clin Biochem. 2004 Feb;37(2):112-9 – reference: 16842626 - BMC Infect Dis. 2006;6:114 – reference: 9620070 - Invest Ophthalmol Vis Sci. 1998 Jun;39(7):1117-24 – reference: 18718524 - Free Radic Biol Med. 2008 Oct 15;45(8):1047-55 – reference: 8339559 - Cornea. 1993 Jul;12(4):310-4 – reference: 16877401 - Invest Ophthalmol Vis Sci. 2006 Aug;47(8):3345-51 – reference: 14700645 - Am J Ophthalmol. 2004 Jan;137(1):62-9 – reference: 17993819 - Eye Contact Lens. 2007 Nov;33(6 Pt 1):265-71 – reference: 18515575 - Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4361-9 – reference: 15790887 - Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1256-63 – reference: 14691728 - Swiss Med Wkly. 2003 Nov 1;133(41-42):563-6 – reference: 10656302 - CLAO J. 2000 Jan;26(1):10-3 – reference: 11527942 - Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2293-6 – reference: 9493273 - Surv Ophthalmol. 1998 Jan-Feb;42(4):297-319 – reference: 11071029 - Eur J Ophthalmol. 2000 Jul-Sep;10(3):215-26 – reference: 21969298 - Invest Ophthalmol Vis Sci. 2011;52(12):8592-7 – reference: 22413749 - Acta Ophthalmol. 2012 Jun;90(4):e303-9 |
SSID | ssj0014770 |
Score | 2.3439534 |
Snippet | Purpose
To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total... To establish the effect of systemic oxidative stress on the pathogenesis of keratoconus by measuring serum total oxidant status (TOS) and total antioxidant... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 285 |
SubjectTerms | 692/420 692/699/3161 Adult Antioxidants - metabolism Biomarkers - blood Clinical Study Female Humans Keratoconus - blood Keratoconus - etiology Keratoconus - physiopathology Laboratory Medicine Male Medicine Medicine & Public Health Ophthalmology Oxidants - blood Oxidative Stress - physiology Pharmaceutical Sciences/Technology Surgery Surgical Oncology |
Title | Increased systemic oxidative stress in patients with keratoconus |
URI | https://link.springer.com/article/10.1038/eye.2013.262 https://www.ncbi.nlm.nih.gov/pubmed/24310241 https://www.proquest.com/docview/1506800255 https://www.proquest.com/docview/1507797347 https://pubmed.ncbi.nlm.nih.gov/PMC3965806 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fa9wwDBbrFcpexra2W7Zb8WDtS0kbx3bsPO0XV8pgZZQW7i04tkOPjaTt3cH23092fOlu7fYckRjJsj5ZyieAdwUvmRWapbyWLuVaoEthHpTmXKIzYUxzdWD7PCtOL_mXqZjGC7d5bKtcnYnhoLad8Xfkx54JTwUE_P76JvVTo3x1NY7Q2IBNPIKVGMHmp8nZt_OhjsBlGBeHOCJLMRJOY-t7xtSx--VZMik7yot8PSjdQ5r3Gyb_qpqGYHTyFJ5EFEk-9mZ_Bo9c-xy2vsY6-TZ8QLf33ebOkp6qeWZI93NmA8s36f8PIbOWRFbVOfHXseS7J1juMEFeznfg8mRy8fk0jbMSUiPybJFSLTSVjNW0bCi3VtSYKaC_1YiQRKNUzQynlhaaGsxQcq5NUeImskZZpXnj2C6M2q51L4FIVXAtndYNrbmwUuN7RO5Ko_KGapUlcLhSVmUikbifZ_GjCgVtpipUbeVVW6FqE9gfpK97Ao1_yI1Xeq-iG82rO6Mn8HZ4jA7gqxq6dd0yyEhZSsZlAi96Mw0fyhEeIQihCcg1Aw4Cnlx7_Uk7uwok28yz4mRFAgcrU_-xrAfW_-r_638Nj1GS991rYxgtbpfuDcKZRb0HG3Iq9-LO_Q3fXvXV |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VVgIuiDeBAkaiXFDa-BU7B8Sz1Za2K4RaaW_BsR11VZQUdlfQP8VvZJwXLAVuPdtxrHnYnz3jbwCepiLjThoei0L5WBiJLoXnoJgJhc6Ee5ovGrbPcTo6Eu8ncrICP_q3MCGtsl8Tm4Xa1TbckW8FJjzdIOCXp1_iUDUqRFf7EhqtWez5s294ZJu92H2H-t1gbGf78O0o7qoKxFayZB5TIw1VnBc0K6lwThaIqdEyC8QSstS64FZQR1NDLWJ5JoxNMxS3s9ppI0rPcdxLsIYwI0MvWnuzPf7wcYhbCNWUp0PcksS48066VPuE6y1_Flg5Kd9kKVveBM8h2_MJmn9EaZvNb-c6XOtQK3ndmtkNWPHVTbh80MXlb8ErXGZCdrt3pKWGnlpSf5-6hlWctO9RyLQiHYvrjITrX3ISCJ1rPJAvZrfh6EKkeAdWq7ry94AonQqjvDElLYR0yuA4kvnMalZSo5MInvfCym1HXB7qZ3zOmwA61zmKNg-izVG0EWwMvU9bwo5_9Fvv5Z53bjvLfxlZBE-GZnS4EEUxla8XTR-lMsWFiuBuq6bhRwzhGIIeGoFaUuDQIZB5L7dU0-OG1JsHFp4kjeBZr-rfpvWX-d____wfw5XR4cF-vr873nsAV_Er0WbOrcPq_OvCP0QoNS8edfZL4NNFu8xP8oEyAA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrVRxQbwJFDAS5YLCxq_YOSBe7aqlsKoQlfYWnNgRK1BS2F1B_xq_jnHiBJYCt57tONZ4xvPZM_4G4GEqMm6l4bEolIuFkWhSeA6KmVBoTOjTXNGyfU7T_WPxeiZnG_Cjfwvj0yr7PbHdqG1T-jvysWfC0y0CHlchLeJod_Ls5EvsK0j5SGtfTqNTkUN3-g2Pb4unB7u41juMTfbev9qPQ4WBuJQsWcbUSEMV5wXNKiqslQXia9TSAnGFrLQueCmopamhJeJ6JkyZZih6W2qrjagcx3EvwKZCr6hHsPlyb3r0bohhCNWWqkMMk8TohWch7T7heuxOPUMn5U9YytYd4hmUezZZ84-IbesIJ5fhUkCw5EWncldgw9VXYettiNFfg-e45fhMd2dJRxM9L0nzfW5bhnHSvU0h85oERtcF8VfB5JMnd27wcL5aXIfjc5HiDRjVTe1uAVE6FUY5YypaCGmVwXEkc1mpWUWNTiJ43AsrLwOJua-l8Tlvg-lc5yja3Is2R9FGsDP0PunIO_7Rb7uXex5MeJH_UrgIHgzNaHw-omJq16zaPkpligsVwc1umYYfMYRmCIBoBGptAYcOnth7vaWef2wJvrln5EnSCB71S_3btP4y_9v_n_992EJTyd8cTA_vwEX8SHRJdNswWn5dubuIqpbFvaC-BD6ct8X8BOr6Niw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increased+systemic+oxidative+stress+in+patients+with+keratoconus&rft.jtitle=Eye+%28London%29&rft.au=Toprak%2C+I&rft.au=Kucukatay%2C+V&rft.au=Yildirim%2C+C&rft.au=Kilic-Toprak%2C+E&rft.date=2014-03-01&rft.issn=0950-222X&rft.eissn=1476-5454&rft.volume=28&rft.issue=3&rft.spage=285&rft.epage=289&rft_id=info:doi/10.1038%2Feye.2013.262&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_eye_2013_262 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-222X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-222X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-222X&client=summon |